Linaclotide clinical trials
Also written Linzess, ASP0456 and MD-1100 Acetate.
How each study uses linaclotide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the linaclotide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Aug 2012 · LINZESS · NDA 202811 (FDA, Drugs@FDA)
- European Union
- 26 Nov 2012 · Constella · EMEA/H/C/002490 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2014 (7)
| Year | Studies |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 31 · Other 13
Ironwood Pharmaceuticals, Inc. (10) · Forest Laboratories (9) · Astellas Pharma Inc (6) · AbbVie (3) · University of Nottingham (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Wisconsin, Madison (1) · Universitaire Ziekenhuizen KU Leuven (1)
Often tested with
Tested in the same studies.
Plecanatide (1) · Lactulose (1) · Polyethylene Glycols (1) · Senna Extract (1) · Sennosides (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test linaclotide.
- Nov 2026Linaclotide in Treating Patients With Stages 0-3 Colorectal CancerPhase 2 · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- May 2027MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)Not applicable · University of Nottingham
Studies
Open first, then newest update. How each study uses linaclotide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 44
- MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)Not yet recruitingNot applicableUniversity of NottinghamNCT07780344Written as Linaclotide 290 microgramsHow we know
- Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisRecruitingEarly Phase 1University of NottinghamNCT07569419Written as Linaclotide 290 microgramsHow we know
- Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for ColonoscopyEnrolling by invitationPhase 4Haifeng LanNCT06748638Written as Lactulose+ linaclotideHow we know
- Linaclotide in Treating Patients With Stages 0-3 Colorectal CancerActive, not recruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityNCT03796884Written as LinaclotideHow we know
- A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional ConstipationCompletedPhase 3AbbVieNCT05652205Written as LinaclotideHow we know
- GCC Agonist Signal in the Small IntestineCompletedPhase 1University of Wisconsin, MadisonNCT05107219Written as LinaclotideHow we know
- A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With LinaclotideCompletedPhase 2AbbVieNCT05760313Written as LinaclotideHow we know
- Effect to Linaclotide on Colonic MotilityCompletedPhase 4Universitaire Ziekenhuizen KU LeuvenNCT06989268Written as Linaclotide 290 microgramsHow we know
- Clinical Study of Bowel Preparation Before ColonoscopyCompletedNot applicableJinling Hospital, ChinaNCT06091735Written as OSS+LinzessHow we know
- Linaclotide Acetate in Preventing Colorectal Cancer in Healthy VolunteersCompletedPhase 1Mayo ClinicNCT01950403Written as linaclotide acetateHow we know
- Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)CompletedPhase 3AbbVieNCT04026113Written as LinaclotideHow we know
- A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic ConstipationCompletedPhase 2Astellas Pharma IncNCT02425722Written as ASP0456How we know
- A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeCompletedPhase 2Astellas Pharma IncNCT01714843Written as linaclotideHow we know
- Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeCompletedPhase 3Astellas Pharma IncNCT02316899Written as linaclotideHow we know
- A Study of Oral Dosing of ASP0456 in Patients With Chronic ConstipationCompletedPhase 3Astellas Pharma IncNCT02809105Written as linaclotideHow we know
- Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional ConstipationCompletedPhase 2AllerganNCT04110145Written as LinaclotideHow we know
- Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal DisordersStatus unknownPhase 4RenJi HospitalNCT05134584Written as LinaclotideHow we know
- A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)TerminatedPhase 4Ironwood Pharmaceuticals, Inc.NCT02837783Written as LinaclotideHow we know
- Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic ConstipationStatus unknownNot applicableSecond Affiliated Hospital of Xi'an Jiaotong UniversityNCT05137145Written as LinaclotideHow we know
- Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic ConstipationStatus unknownPhase 3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT04804267Written as LinaclotideHow we know
Codes
What other systems call linaclotide · ClinicalTrials.gg INT005166
- MeSH (NLM) C523483linaclotideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) N0TXR0XR5XLINACLOTIDEConfirmed FDA, NLM
- RxNorm 1307404One source FDA
- NCI Thesaurus C81001LinaclotideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C523483 | linaclotide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | N0TXR0XR5X | LINACLOTIDE | Confirmed FDA, NLM |
| RxNorm | 1307404 | — | One source FDA |
| NCI Thesaurus | C81001 | Linaclotide | One source FDA |
Also registered as linaclotide acetate (UNII NSF067KU1M).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.